Report Content
Chapter 1 Methodology
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Automated immunoassay analyzers industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product trends
2.1.4 Application trends
2.1.5 End-use trends
Chapter 3 Automated Immunoassay Analyzers Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Incessant introduction of advanced products
3.2.1.2 Rising trend towards lab automation
3.2.1.3 Increasing prevalence of infectious diseases
3.2.1.4 Expanding clinical applications of immunoassay analyzers
3.2.2 Industry pitfalls & challenges
3.2.2.1 Dearth of qualified and trained professionals
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By application
3.3.3 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.5.3 Asia Pacific
3.6 Future market trends
3.7 Automated immunoassay analyzers product outline
3.8 Technology landscape
3.9 Global market share analysis, by settings and application
3.10 Gap analysis
3.11 Porter’s analysis
3.12 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive positioning matrix
4.4 Company market share analysis, 2022
4.4.1 Global
4.4.2 North America
4.4.3 Europe
4.4.4 Asia Pacific
4.4.5 Latin America
4.4.6 MEA
4.5 Vendor matrix analysis
4.6 Strategy dashboard, 2022
Chapter 5 Automated Immunoassay Analyzers Market Size and Forecast, By Product (USD Million & Units)
5.1 Key trends, product
5.2 Immunofluorescence
5.3 Chemiluminescence
5.4 ELISA (enzyme-linked immunosorbent assay)
5.5 Enzyme linked fluorescent system
5.6 Multiplexed assay system
5.7 Radioimmunoassay
Chapter 6 Automated Immunoassay Analyzers Market Size and Forecast, By Application (USD Million)
6.1 Key trends, application
6.2 Infectious disease
6.2.1 Influenza
6.2.2 HIV
6.2.3 Hepatitis C
6.2.4 Sexually Transmitted Disease (STD)
6.2.5 Healthcare-Associated Infection (HAI)
6.2.6 Respiratory infection
6.2.7 Tropical disease
6.2.8 Others
6.3 Endocrinology
6.4 Drug Monitoring
6.5 Cardiology
6.6 Oncology
6.7 Allergy Testing
6.8 Others
Chapter 7 Automated Immunoassay Analyzers Market Size and Forecast, By End-use (USD Million)
7.1 Key trends, end-use
7.2 Hospitals
7.3 Diagnostic Laboratories
7.4 Research and Academic Laboratories
7.5 Pharmaceutical and Biotechnology Companies
7.6 Others
Chapter 8 Automated Immunoassay Analyzers Market Size and Forecast, By Region (USD Million)
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Poland
8.3.7 Sweden
8.3.8 Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Philippines
8.4.8 Vietnam
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Columbia
8.5.5 Chile
8.5.6 Peru
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Turkey
8.6.5 Israel
8.6.6 Iran
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 BioMerieux
9.3 F. Hoffmann-La Roche AG
9.4 Becton Dickinson and Company
9.5 Biokit
9.6 Carolina Liquid Chemistries Corporation
9.7 Inova DX
9.8 Luminex Corporation
9.9 Meril Life Sciences
9.10 Ortho Clinical Diagnostics
9.11 Randox Laboratories
9.12 Siemens Healthcare
9.13 BioRad Laboratories
9.14 Aesku Diagnotics
9.15 Arlington Scientific
9.16 Perkin Elmer
9.17 Diasorin
